AIDS Rev. 2005 Jan-Mar;7(1):56-61.

Kaposi's sarcoma in the era of HAART-an update on mechanisms, diagnostics and treatment.

Dittmer DP, Vahrson W, Staudt M, Hilscher C, Fakhari FD.

Source

Department of Microbiology and Immunology, University of North Carolina, Chapel Hill, NC 27599-7290, USA. ddittmer@med.unc.edu

Abstract

Kaposi's Sarcoma (KS) signified the AIDS epidemic in the 1980's and led to the discovery of the eighth human herpesvirus, KS-associated herpesvirus (KSHV), as the causative agent for this disease. Today we know a lot about KSHV and can begin to understand, diagnose and treat KS as a viral disease rather than another sarcoma.

PMID:: 15875661; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Grant Support

Publication Types

MeSH Terms

Grant Support

CA109232/CA/NCI NIH HHS/United States

LinkOut - more resources

Other Literature Sources

Medical

Supplemental Content

Related citations

Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma. [AIDS. 2007]
Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma.
Bihl F, Mosam A, Henry LN, Chisholm JV 3rd, Dollard S, Gumbi P, Cassol E, Page T, Mueller N, Kiepiela P, et al. AIDS. 2007 Jun 19; 21(10):1245-52.
Review Management of Kaposi's sarcoma in resource-limited settings in the era of HAART. [AIDS Rev. 2005]
Review Management of Kaposi's sarcoma in resource-limited settings in the era of HAART.
Lynen L, Zolfo M, Huyst V, Louis F, Barnardt P, Van de Velde A, De Schacht C, Colebunders R. AIDS Rev. 2005 Jan-Mar; 7(1):13-21.
Monitoring of endogenous interferon-alpha and human herpesvirus 8 in HIV-infected patients with Kaposi's sarcoma. [Eur J Med Res. 2002]
Monitoring of endogenous interferon-alpha and human herpesvirus 8 in HIV-infected patients with Kaposi's sarcoma.
Plettenberg A, Albrecht D, Lorenzen T, Meyer T, Arndt R, Stoehr A. Eur J Med Res. 2002 Jan 29; 7(1):19-24.
Restricted Kaposi's sarcoma (KS) herpesvirus transcription in KS lesions from patients on successful antiretroviral therapy. [MBio. 2011]
Restricted Kaposi's sarcoma (KS) herpesvirus transcription in KS lesions from patients on successful antiretroviral therapy.
Dittmer DP. MBio. 2011; 2(6):e00138-11. Epub 2011 Nov 1.
Review HIV-associated Kaposi's sarcoma. [Dermatol Clin. 2006]
Review HIV-associated Kaposi's sarcoma.
Jessop S. Dermatol Clin. 2006 Oct; 24(4):509-20, vii.

See reviews... See all...

Cited by 2 PubMed Central articles

Review Role of the ubiquitin system and tumor viruses in AIDS-related cancer. [BMC Biochem. 2007]
Review Role of the ubiquitin system and tumor viruses in AIDS-related cancer.
Shackelford J, Pagano JS. BMC Biochem. 2007 Nov 22; 8 Suppl 1:S8. Epub 2007 Nov 22.
Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling. [Blood. 2007]
Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling.
Sin SH, Roy D, Wang L, Staudt MR, Fakhari FD, Patel DD, Henry D, Harrington WJ Jr, Damania BA, Dittmer DP. Blood. 2007 Mar 1; 109(5):2165-73. Epub 2006 Nov 2.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Kaposi's sarcoma in the era of HAART-an update on mechanisms, diagnostics and tr...
Kaposi's sarcoma in the era of HAART-an update on mechanisms, diagnostics and treatment.
AIDS Rev. 2005 Jan-Mar ;7(1):56-61.

PubMed
The quality of medical care provided to vulnerable community-dwelling older pati...
The quality of medical care provided to vulnerable community-dwelling older patients.
Ann Intern Med. 2003 Nov 4 ;139(9):740-7.

PubMed
99mTc-labelled rituximab, a new non-Hodgkin's lymphoma imaging agent: first clin...
99mTc-labelled rituximab, a new non-Hodgkin's lymphoma imaging agent: first clinical experience.
Nucl Med Commun. 2008 Dec ;29(12):1059-65.

PubMed
Objective measurements of lower-level visual stress.
Objective measurements of lower-level visual stress.
Optom Vis Sci. 2007 Jul ;84(7):620-9.

PubMed
Medication use by athletes at the Athens 2004 Summer Olympic Games.
Medication use by athletes at the Athens 2004 Summer Olympic Games.
Clin J Sport Med. 2009 Jan ;19(1):33-8.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: